Detection method (n = 1045)
|
Screening
|
Ref.
| | | |
Ref.
| | | |
Interval
|
0.6
|
0.4
|
0.9
|
0.017
|
0.8
|
0.4
|
1.4
|
0.408
|
Age (n = 1045)
| | | | | | | | |
50–54
|
Ref.
| | | |
Ref.
| | | |
55–59
|
1.1
|
0.7
|
1.9
|
0.618
|
1.0
|
0.5
|
2.0
|
0.967
|
60–64
|
0.9
|
0.5
|
1.5
|
0.632
|
0.7
|
0.3
|
1.6
|
0.424
|
65–70
|
0.7
|
0.4
|
1.3
|
0.282
|
0.7
|
0.3
|
1.7
|
0.432
|
Charlson index (n = 1045)
|
0
|
Ref.
| | | |
Ref.
| | | |
1
|
2.3
|
1.5
|
3.7
|
<0.001
|
2.8
|
1.4
|
5.4
|
<0.01
|
> =2
|
3.0
|
1.8
|
5.2
|
<0.001
|
4.5
|
2.1
|
9.5
|
<0.001
|
Histological type (n = 1038)
|
In situ
|
Ref.
| | | |
Ref.
| | | |
Ductal
|
6.4
|
1.5
|
26.4
|
<0.05
|
0.5
|
0.1
|
4.2
|
0.534
|
Lobular
|
7.6
|
1.7
|
34.4
|
<0.01
|
1.1
|
0.5
|
2.7
|
0.784
|
Other
|
4.1
|
0.8
|
20.5
|
0.082
|
0.6
|
0.2
|
2.1
|
0.422
|
Phenotype (n = 763)
| | | | | | | | |
Luminal A
|
Ref.
| | | |
Ref.
| | | |
Luminal B
|
0.5
|
0.3
|
1.1
|
0.074
|
0.6
|
0.3
|
1.3
|
0.219
|
Her2
|
0.7
|
0.3
|
1.9
|
0.495
|
0.8
|
0.3
|
2.3
|
0.713
|
Triple negative
|
1.0
|
0.5
|
2.2
|
0.903
|
1.1
|
0.5
|
2.6
|
0.800
|
Axillary treatmentb (n = 983)
|
Only SLNB
|
Ref.
| | | |
Ref.
| | | |
ALND
|
2.2
|
1.3
|
3.7
|
<0.05
|
2.0
|
1.0
|
4.0
|
<0.05
|
Neoadjuvant treatment (n = 1045)
|
No
|
Ref.
| | | |
Ref.
| | | |
Yes
|
0.5
|
0.2
|
1.1
|
0.095
|
0.4
|
0.1
|
1.3
|
0.132
|
Chemotherapy after surgery (n = 1018)
| |
No
|
Ref.
| | | |
Ref.
| | | |
Yes
|
1.8
|
1.2
|
2.8
|
<0.01
|
1.4
|
0.7
|
2.5
|
0.334
|